Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma.

× No keyword cloud information.

4 in total

1. Assessing the effectiveness of a Grand Rounds CME activity for health-care professionals.

Authors: Terry Ann Glauser; P Holder Nevins; J Chad Williamson; Brian Tomlinson
Journal: J Cancer Educ Date: 2013-09 Impact factor: 2.037

Review 2. Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.

Authors: Ruth Pettengell; Matti Aapro; Ercole Brusamolino; Dolores Caballero; Bertrand Coiffier; Michael Pfreundschuh; Marek Trneny; Jan Walewski
Journal: Clin Drug Investig Date: 2009 Impact factor: 2.859

3. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.

Authors: Michael L Wang; Simon Rule; Peter Martin; Andre Goy; Rebecca Auer; Brad S Kahl; Wojciech Jurczak; Ranjana H Advani; Jorge E Romaguera; Michael E Williams; Jacqueline C Barrientos; Ewa Chmielowska; John Radford; Stephan Stilgenbauer; Martin Dreyling; Wieslaw Wiktor Jedrzejczak; Peter Johnson; Stephen E Spurgeon; Lei Li; Liang Zhang; Kate Newberry; Zhishuo Ou; Nancy Cheng; Bingliang Fang; Jesse McGreivy; Fong Clow; Joseph J Buggy; Betty Y Chang; Darrin M Beaupre; Lori A Kunkel; Kristie A Blum
Journal: N Engl J Med Date: 2013-06-19 Impact factor: 91.245

4. Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk.

Authors: Cuicui Lyu; Rui Cui; Jia Wang; Nan Mou; Yanyu Jiang; Wei Li; Qi Deng
Journal: Front Oncol Date: 2021-07-30 Impact factor: 6.244

4 in total